Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  hydroxychloroquine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-11 of 11 for your search:
Start Over
Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 1 to 29
Sponsor: NCI, Other
Protocol IDs: ASCT0031, COG-ASCT0031, CCG-S9701, NCI-P02-0213, NCT00031824
Hydroxychloroquine, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NABTT-0603 CDR0000549734, U01CA062475, ABTC-0603, NABTT-0603, 0603, NCT00486603
Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: UPCI 09-122, PO1101944, NCT01128296
Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 080803, P30CA072720, 0220080115, NCI-2012-00528, CINJ-080803, NCT00726596
Hydroxychloroquine in Untreated B-CLL Patients
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: Over 18
Sponsor: Other
Protocol IDs: 08-088, NCT00771056
Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 070806, CINJ-070806, P30CA072720, NCT01006369
Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-097, OSI4620s, NCT00977470
Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-310, NCT01273805
Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03112, CTEP #8342, 050909, 8342, P30CA072720, U01CA132194, CINJ-050801, 050801, 0220080281, NCT00813423
Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 090901, P30CA072720, CDR0000648156, CINJ-090901, NCT00962845
Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCC 09411, NCT01396200
Start Over